Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the (Q36793290)
Jump to navigation
Jump to search
scientific article published on 11 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the |
scientific article published on 11 March 2013 |
Statements
1 reference
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the (English)
1 reference
Julie M Vose
1 reference
Edward A Stadtmauer
1 reference
Shelly Carter
1 reference
Linda J Burns
1 reference
Ernesto Ayala
1 reference
Oliver W Press
1 reference
Craig H Moskowitz
1 reference
Shin Mineshi
1 reference
Richard Ambinder
1 reference
Timothy Fenske
1 reference
Mary Horowitz
1 reference
Richard Fisher
1 reference
Marcie Tomblyn
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference